Simrat Randhawa is CHIEF MEDICAL OFFICER of Magenta Therapeutics, Inc.. Currently has a direct ownership of 4,000 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Sep 22, 2023, when has been sold 2,000 shares (Common Stock) at a price of $13.2 per share, resulting in proceeds of $26,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4K
0% 3M change
0% 12M change
Total Value Held $0

Simrat Randhawa Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 22 2023
BUY
Open market or private purchase
$26,400 $13.2 p/Share
2,000 Added 33.33%
4,000 Common Stock
Sep 21 2023
BUY
Open market or private purchase
$26,400 $13.2 p/Share
2,000 Added 50.0%
2,000 Common Stock
SR

Simrat Randhawa

CHIEF MEDICAL OFFICER
New York, NY

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Track Activities on MGTA